Brokerages Set Certara, Inc. (NASDAQ:CERT) PT at $15.92

Shares of Certara, Inc. (NASDAQ:CERTGet Free Report) have been given an average recommendation of “Hold” by the eight ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $15.92.

Several brokerages have recently weighed in on CERT. Robert W. Baird reduced their price target on Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday, November 5th. UBS Group upgraded Certara from a “neutral” rating to a “buy” rating and set a $16.00 target price on the stock in a research note on Friday, September 27th. Finally, Barclays lowered their target price on shares of Certara from $14.00 to $12.00 and set an “equal weight” rating for the company in a research note on Thursday, November 7th.

View Our Latest Stock Analysis on CERT

Certara Stock Down 5.4 %

NASDAQ CERT opened at $9.96 on Monday. Certara has a 52 week low of $9.88 and a 52 week high of $19.87. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of -49.80, a PEG ratio of 5.04 and a beta of 1.51. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.28. The company has a fifty day moving average of $10.90 and a two-hundred day moving average of $13.43.

Certara (NASDAQ:CERTGet Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of $0.11 by $0.02. The company had revenue of $94.80 million for the quarter, compared to the consensus estimate of $95.51 million. Certara had a negative net margin of 8.34% and a positive return on equity of 3.43%. The firm’s revenue was up 10.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.06 EPS. On average, analysts predict that Certara will post 0.28 earnings per share for the current year.

Insider Transactions at Certara

In other news, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $11.29, for a total transaction of $578,318.96. Following the transaction, the insider now directly owns 99,704 shares in the company, valued at approximately $1,125,658.16. This trade represents a 33.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Patrick F. Smith sold 5,409 shares of Certara stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $11.03, for a total transaction of $59,661.27. Following the transaction, the insider now directly owns 50,091 shares in the company, valued at approximately $552,503.73. The trade was a 9.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.39% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in CERT. Brown Brothers Harriman & Co. purchased a new stake in shares of Certara during the 3rd quarter worth $27,292,000. Wasatch Advisors LP lifted its position in shares of Certara by 22.4% during the third quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock valued at $105,577,000 after buying an additional 1,651,076 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Certara by 40.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company’s stock valued at $45,691,000 after buying an additional 1,128,006 shares during the last quarter. Daventry Group LP boosted its holdings in shares of Certara by 153.0% in the 2nd quarter. Daventry Group LP now owns 1,308,572 shares of the company’s stock valued at $18,124,000 after buying an additional 791,405 shares in the last quarter. Finally, Glenmede Trust Co. NA grew its position in shares of Certara by 78.6% in the 3rd quarter. Glenmede Trust Co. NA now owns 1,206,069 shares of the company’s stock worth $14,123,000 after buying an additional 530,598 shares during the last quarter. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

About Certara

(Get Free Report

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Further Reading

Analyst Recommendations for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.